z-logo
Premium
Paving a regulatory pathway for phage therapy
Author(s) -
Huys Isabelle,
Pirnay JeanPaul,
Lavigne Rob,
Jennes Serge,
De Vos Daniel,
Casteels Minne,
Verbeken Gilbert
Publication year - 2013
Publication title -
embo reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.584
H-Index - 184
eISSN - 1469-3178
pISSN - 1469-221X
DOI - 10.1038/embor.2013.163
Subject(s) - phage therapy , bacteria , antibiotic therapy , bacteriophage , biology , antibiotics , medicine , microbiology and biotechnology , genetics , gene , escherichia coli
The growing problem of antibiotic‐resistant bacteria has re‐kindled interest in phage‐based therapies. Yet, the use of phages to treat life‐threatening bacterial infections is held back by the lack of an appropriate regulatory framework for phage therapy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here